Cancer Prevention Pharmaceuticals IPO Research Information

Cancer Prevention Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Cancer Prevention Pharmaceuticals , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Cancer Prevention Pharmaceuticals	CPP - NYSE	Withdrawn	$0.00	$0.00	1.25 million
Underwriter(s): Aegis Capital
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2015-12-23 Terms added 2016-02-03 Underwriter Change 2016-04-19

About Cancer Prevention Pharmaceuticals (adapted from Cancer Prevention Pharmaceuticals prospectus):
They are a clinical-stage biopharmaceutical company formed primarily to develop and commercialize therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases (i.e., rare diseases) and gastrointestinal conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CPP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.